News and Events
Ribbon Biolabs is Falling Walls Winner 2022
We are thrilled to be shortlisted as one of 25 winners of the Falling Walls Venture 2022! Falling Walls Venture is a global platform for the most promising science start-ups who have successfully turned science into business, proving how entrepreneurial solutions can...
Ribbon Biolabs’ first patent issued by the US Patent Office
We are very proud to announce the issuance of our first U.S. patent (US 11352619 B2) covering our novel method for synthesizing double stranded DNA using a diverse library of oligonucleotides. The patent enables us to proprietarily exploit our differentiating...
Ribbon Biolabs is ‘Born Global Champion 2022’
Ribbon Biolabs is very honoured to be one of 15 innovative Start-ups awarded as 'Born Global Champions'. The award is presented annually by the Austrian Economic Chamber to young companies that have succeeded in positioning innovative products and services worldwide...
Meet us at SynBioBeta Conference!
After a couple of years of online meetings, we'll join this year's Global Synthetic Biology Conference on April 12-13 LIVE in Oakland! The conference is hosted by Built with Biology (formerly SynBioBeta), an innovation network for biological engineers, investors,...
Ribbon Biolabs Raises 18 M EUR Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology
January 31, 2022, VIENNA, AUSTRIA: Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from...
Ribbon Biolabs successfully synthesises a 10 kbp DNA molecule using their FullGenes platform
Ribbon Biolabs successfully synthesises a 10 kbp DNA molecule using their FullGenes platform 21 May 2021, Vienna, Austria: The DNA Synthesis company Ribbon Biolabs announces the achievement of a key technology milestone, underlining its capability and potential. Using...
Meet us at SynBioBeta BioPharma!
For the first time ever, SynBioBeta is hosting a special, one-day special on all hot topics in biopharma. We are looking forward to meeting you there! https://synbiobetaevents.com/biopharma-conference-2021
Ribbon Biolabs’ Advisory Board member Eörs Szathmary elected to Norwegian Academy of Sciences
Prof. Eörs Szathmary of Eötvös University in Hungary has been elected to the Humanities and Social Sciences section of the Norwegian Academy of Sciences and Letters. As a member of Ribbon Biolabs’ Advisory Board, he has been supporting the companies development since...
Meet us (virtually) at the 12th Annual ÖGMBT Meeting
Meet us on September 23 and the Life Science Career Fair! The Annual ÖGMBT Meeting is the melting pot of the Austrian Life Science Community – this year it is held virtually and will kick-off a 6 month VirtualExpo and Life Science Career Fair, the place to be for...
Funding the future: The race for a vaccine
Ribbon Biolabs’ CEO is discussing the funds required to develop a coronavirus vaccine in an online special event organized by the online magazine Metropole: https://metropole.at/funding-a-new-future-the-race-for-a-vaccine/